Antares Pharma Inc (USD)
ATRS
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.77 | 2.86
52-Wk Range- | -
Last Close2.86
Mkt Cap (m)475.03
Dividend yield-
ISINUS0366421065
Volume2,034,502.00
Exchange VenueNAS

Company Profile

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

Key Information
Price/Earning73.51
Price/Book8.29
Price/Sales3.42
P/CF47.89
Rev Growth (3 year avg)33.36
EPS Growth (3 year avg)-
Operating Margin % 0.80
Net Margin %-1.64
Return on Equity-4.34
Debt/Equity0.86

Documents

Prospectus
en 11/08/2017
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.antarespharma.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)26.5045.6652.2254.5263.55123.86
Operating Income (m)-35.11-20.46-24.12-16.45-16.600.99
Net Income (m)-35.15-20.66-24.34-16.74-6.52-2.03
Basic EPS-0.27-0.14-0.16-0.11-0.04-0.01
Avg. Diluted Shares Outstanding (m)130.55146.59154.99156.05157.41162.57
Balance Sheet
USD201420152016201720182019
Current Assets (m)53.6466.0645.2655.5471.31108.45
Non Current Assets (m)15.1418.5021.0618.8016.9724.31
Total Assets (m)68.7784.5666.3374.3488.28132.75
Current Liabilities (m)24.2316.8219.9115.7327.1932.42
Total Liabilities (m)------
Total Equity (m)41.2067.0445.2233.5539.0054.50
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-26.33-28.20-15.19-23.09-17.32-10.62
Capital Expenditure (m)-5.65-6.69-5.01-1.27-0.89-2.35
Figures are quoted in USD unless stated otherwise
-
No change
$
2.86
Last Price